Patents by Inventor Josef Miller
Josef Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8927528Abstract: A composition to be administered to a mammal for treating hearing loss is disclosed herein. The composition consists essentially of a biologically effective amount of vitamin A, vitamin C, vitamin E, and a vasodilator comprising magnesium. The composition optionally includes a withanolide and/or resveratrol. The vitamin A, vitamin C, vitamin E, and the vasodilator comprising magnesium provides an additive effect that is equal to or greater than a sum of the effects of the individual components.Type: GrantFiled: November 16, 2012Date of Patent: January 6, 2015Assignee: The Regents of the University of MichiganInventors: Josef Miller, Colleen LePrell, Jochen Schact, Diane Prieskorn
-
Patent number: 8338397Abstract: A method of treating side effects of antibiotic treatment includes the step of internally administering an antibiotic that is capable of inducing hearing loss in a mammal. The method further includes the step of internally administering a composition to the mammal in conjunction with administration of the antibiotic. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, vitamin E, vitamin C, and a vasodilator comprising magnesium. The combination of vitamins and the vasodilator comprising magnesium, in the biologically effective amounts, provides an effective treatment for treating side effects of antibiotic treatment.Type: GrantFiled: April 15, 2010Date of Patent: December 25, 2012Assignee: The Regents of the University of MichiganInventor: Josef Miller
-
Patent number: 8338398Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is equal to or greater than a sum of the effect of the individual components. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, a donor antioxidant, a third antioxidant, and a vasodilator. A method of treating hearing loss includes the step of internally administering the composition including a biologically effective amount of the at least one scavenger of singlet oxygen, the donor antioxidant, the third antioxidant, and the vasodilator to a mammal within three days of trauma to a middle or inner ear of the mammal.Type: GrantFiled: April 21, 2011Date of Patent: December 25, 2012Assignee: The Regents of the University of MichiganInventors: Josef Miller, Colleen LePrell, Jochen Schact, Diane Prieskorn
-
Publication number: 20110280964Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is equal to or greater than a sum of the effect of the individual components. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, a donor antioxidant, a third antioxidant, and a vasodilator. A method of treating hearing loss includes the step of internally administering the composition including a biologically effective amount of the at least one scavenger of singlet oxygen, the donor antioxidant, the third antioxidant, and the vasodilator to a mammal within three days of trauma to a middle or inner ear of the mammal.Type: ApplicationFiled: April 21, 2011Publication date: November 17, 2011Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Josef Miller, Colleen LePrell, Jochen Schacht, Diane Prieskorn
-
Patent number: 8053424Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is greater than the effect of the individual components alone. The composition includes a biologically effective amount of vitamin E for inhibiting propagation of lipid peroxidation that contributes to hearing loss. The composition also includes a biologically effective amount of a salicylate for reducing hydroxyl radicals that contribute to hearing loss. A method of treating hearing loss includes the step of internally administering the composition, as described above, to a mammal within three days of trauma to a middle or inner ear of the mammal. In other words, the composition is effective even when administered as late as three days after trauma to a middle or inner ear of a mammal.Type: GrantFiled: July 19, 2010Date of Patent: November 8, 2011Assignee: The Regents of the University of MichiganInventors: Josef Miller, Colleen Garbe-LePrell, Daisuke Yamashita
-
Patent number: 7951845Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is equal to or greater than a sum of the effect of the individual components. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, a donor antioxidant, a third antioxidant, and a vasodilator. A method of treating hearing loss includes the step of internally administering the composition including a biologically effective amount of the at least one scavenger of singlet oxygen, the donor antioxidant, the third antioxidant, and the vasodilator to a mammal within three days of trauma to a middle or inner ear of the mammal.Type: GrantFiled: January 17, 2007Date of Patent: May 31, 2011Assignee: The Regents of the University of MichiganInventors: Josef Miller, Colleen LePrell, Jochen Schacht, Diane Prieskorn
-
Publication number: 20100305075Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is greater than the effect of the individual components alone. The composition includes a biologically effective amount of vitamin E for inhibiting propagation of lipid peroxidation that contributes to hearing loss. The composition also includes a biologically effective amount of a salicylate for reducing hydroxyl radicals that contribute to hearing loss. A method of treating hearing loss includes the step of internally administering the composition, as described above, to a mammal within three days of trauma to a middle or inner ear of the mammal. In other words, the composition is effective even when administered as late as three days after trauma to a middle or inner ear of a mammal.Type: ApplicationFiled: July 19, 2010Publication date: December 2, 2010Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Josef Miller, Colleen Garbe-LePrell, Daisuke Yamashita
-
Patent number: 7786100Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is greater than the effect of the individual components alone. The composition includes a biologically effective amount of vitamin E for inhibiting propagation of lipid peroxidation that contributes to hearing loss. The composition also includes a biologically effective amount of a salicylate for reducing hydroxyl radicals that contribute to hearing loss. A method of treating hearing loss includes the step of internally administering the composition, as described above, to a mammal within three days of trauma to a middle or inner ear of the mammal. In other words, the composition is effective even when administered as late as three days after trauma to a middle or inner ear of a mammal.Type: GrantFiled: March 20, 2006Date of Patent: August 31, 2010Assignee: The Regents of the University of MichiganInventors: Josef Miller, Colleen Garbe-LePrell, Daisuke Yamashita
-
Publication number: 20100215746Abstract: The present invention relates to compositions and methods for the protection and restoration of hearing. In particular, the present invention relates to methods and compositions for the prevention of chemical (e.g., cisplatin) induced deafness. The present invention thus provides methods of improving the outcome of subjects treated with cisplatin.Type: ApplicationFiled: March 5, 2010Publication date: August 26, 2010Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Goran Laurell, Andreas Ekborn, Josef Miller, Hans Ehrsson
-
Publication number: 20100203169Abstract: A method of treating side effects of antibiotic treatment includes the step of internally administering an antibiotic that is capable of inducing hearing loss in a mammal. The method further includes the step of internally administering a composition to the mammal in conjunction with administration of the antibiotic. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, vitamin E, vitamin C, and a vasodilator comprising magnesium. The combination of vitamins and the vasodilator comprising magnesium, in the biologically effective amounts, provides an effective treatment for treating side effects of antibiotic treatment.Type: ApplicationFiled: April 15, 2010Publication date: August 12, 2010Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventor: Josef Miller
-
Patent number: 7700134Abstract: The present invention relates to compositions and methods for the protection and restoration of hearing. In particular, the present invention relates to methods and compositions for the prevention of chemical (e.g., cisplatin) induced deafness. The present invention thus provides methods of improving the outcome of subjects treated with cisplatin.Type: GrantFiled: January 16, 2003Date of Patent: April 20, 2010Assignee: The Regents of the University of MichiganInventors: Goran Laurell, Andreas Ekborn, Josef Miller, Hans Ehrsson
-
Publication number: 20070219167Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is greater than the effect of the individual components alone. The composition includes a biologically effective amount of vitamin E for inhibiting propagation of lipid peroxidation that contributes to hearing loss. The composition also includes a biologically effective amount of a salicylate for reducing hydroxyl radicals that contribute to hearing loss. A method of treating hearing loss includes the step of internally administering the composition, as described above, to a mammal within three days of trauma to a middle or inner ear of the mammal. In other words, the composition is effective even when administered as late as three days after trauma to a middle or inner ear of a mammal.Type: ApplicationFiled: March 20, 2006Publication date: September 20, 2007Inventors: Josef Miller, Colleen Garbe-LePrell, Daisuke Yamashita
-
Publication number: 20070165870Abstract: A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is equal to or greater than a sum of the effect of the individual components. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, a donor antioxidant, a third antioxidant, and a vasodilator. A method of treating hearing loss includes the step of internally administering the composition including a biologically effective amount of the at least one scavenger of singlet oxygen, the donor antioxidant, the third antioxidant, and the vasodilator to a mammal within three days of trauma to a middle or inner ear of the mammal.Type: ApplicationFiled: January 17, 2007Publication date: July 19, 2007Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Josef Miller, Colleen LePrell, Jochen Schacht, Diane Prieskorn
-
Patent number: 6634414Abstract: A pressure die casting machine is provided for processing fused metals in which the die locking unit is mounted adjustably on a lifting frame that can be vertically raised or lowered to adapt the die locking unit to the casting nozzle via lever sets and a common mechanical adjusting device for these lever sets. This arrangement achieves a space-saving arrangement with a simplified design.Type: GrantFiled: June 7, 2002Date of Patent: October 21, 2003Assignee: Oskar Frech GmbH & Co.Inventor: Josef Miller
-
Publication number: 20030180388Abstract: The present invention relates to compositions and methods for the protection and restoration of hearing. In particular, the present invention relates to methods and compositions for the prevention of chemical (e.g., cisplatin) induced deafness. The present invention thus provides methods of improving the outcome of subjects treated with cisplatin.Type: ApplicationFiled: January 16, 2003Publication date: September 25, 2003Applicant: The Regents of the University of MichiganInventors: Goran Laurell, Andreas Ekborn, Josef Miller, Hans Ehrsson
-
Publication number: 20020185246Abstract: A pressure die casting machine is provided for processing fused metals in which the die locking unit is mounted adjustably on a lifting frame that can be vertically raised or lowered to adapt the die locking unit to the casting nozzle via lever sets and a common mechanical adjusting device for these lever sets. This arrangement achieves a space-saving arrangement with a simplified design.Type: ApplicationFiled: June 7, 2002Publication date: December 12, 2002Applicant: Oskar Frech GmbH + Co.Inventor: Josef Miller